Matthew J Zaya1, Ronald N Hines, Jeffrey C Stevens
1Pfizer, Inc., Kalamazoo, MI 49001, USA. matthew.j.zaya@pfizer.com
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Epirubicin detoxification via UGT2B7-dependent glucuronidation increases with age. This study in pediatric liver microsomes found higher UGT2B7 activity and content in older children and adults, supporting epirubicin use in pediatric patients over six months old.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: